Association of the Timing of Atrial Fibrillation Detection and Insular Involvement With the Risk of Embolic Events After Acute Ischemic Stroke

Atrial Fibrillation Detected before or after Stroke: Role of Anticoagulation

(2023) Flurina Lyrer et al.   ANNALS OF NEUROLOGY

Differences in Stroke Recurrence Risk Between Atrial Fibrillation Detected on ECG and 14-Day Cardiac Monitoring

(2023) Alonso Alvarado-Bolaños et al.   STROKE

Practical “1-2-3-4-Day” Rule for Starting Direct Oral Anticoagulants After Ischemic Stroke With Atrial Fibrillation: Combined Hospital-Based Cohort Study

(2022) Shunsuke Kimura et al.   STROKE

Atrial Fibrillation Detected After Stroke and Transient Ischemic Attack: A Novel Clinical Concept Challenging Current Views

(2022) Luciano A. Sposato et al.   STROKE

Neurogenic cardiac outcome in patients after acute ischemic stroke: The brain and heart connection

(2022) Jiangyong Min et al.   Journal of Stroke & Cerebrovascular Diseases

Differences between Atrial Fibrillation Detected before and after Stroke and TIA: A Systematic Review and Meta-Analysis

(2021) Sebastian Fridman et al.   CEREBROVASCULAR DISEASES

Post-Stroke Cardiovascular Complications and Neurogenic Cardiac Injury

(2020) Luciano A. Sposato et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Rivaroxaban administration after acute ischemic stroke: The RELAXED study

(2019) Masahiro Yasaka et al.   PLoS One

Brain-heart interaction revisited: Takotsubo syndrome secondary to seizures

(2019) Jan F. Scheitz et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Two-Year Outcomes of Anticoagulation for Acute Ischemic Stroke With Nonvalvular Atrial Fibrillation　― SAMURAI-NVAF Study ―

(2018) Sohei Yoshimura et al.   CIRCULATION JOURNAL

Linking stroke-induced heart injury and neurogenic atrial fibrillation: a hypothesis to be proven

(2018) Luciano A. Sposato et al.   JOURNAL OF ELECTROCARDIOLOGY

Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study

(2016) Shoji Arihiro et al.   International Journal of Stroke

Design and Rationale of the RELAXED (Recurrent Embolism Lessened by rivaroxaban, an Anti-Xa agent, of Early Dosing for acute ischemic stroke and transient ischemic attack with atrial fibrillation) Study

(2016) Masahiro Yasaka et al.   Journal of Stroke & Cerebrovascular Diseases

Design and Rationale of the RELAXED (Recurrent Embolism Lessened by rivaroxaban, an Anti-Xa agent, of Early Dosing for acute ischemic stroke and transient ischemic attack with atrial fibrillation) Study

(2016) Masahiro Yasaka et al.   Journal of Stroke & Cerebrovascular Diseases

Trends in Oral Anticoagulant Choice for Acute Stroke Patients with Nonvalvular Atrial Fibrillation in Japan: The SAMURAI-NVAF Study

(2015) Kazunori Toyoda et al.   International Journal of Stroke

Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis

(2015) Luciano A Sposato et al.   LANCET NEUROLOGY

Poststroke atrial fibrillation: Cause or consequence?: Critical review of current views

(2014) L. A. Sposato et al.   NEUROLOGY

Atrial Fibrillation in Patients with Cryptogenic Stroke

(2014) David J. Gladstone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cryptogenic Stroke and Underlying Atrial Fibrillation

(2014) Tommaso Sanna et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban vs. Warfarin in Japanese Patients With Atrial Fibrillation

(2012) Masatsugu Hori et al.   CIRCULATION JOURNAL

Model-based Dose Selection for Phase III Rivaroxaban Study in Japanese Patients with Non-valvular Atrial Fibrillation

(2012) Takahiko Tanigawa et al.   Drug Metabolism and Pharmacokinetics